Free Trial
NASDAQ:SEER

Seer Q3 2026 Earnings Date & Estimates

Seer logo
$1.79 +0.06 (+3.41%)
As of 09:37 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Seer is estimated to report Q3 2026 earnings on Tuesday, November 10, 2026, after market closes. The conference call is scheduled for 4:30 PM ET.

Upcoming Earnings Announcement

Quarter
Q3 2026
Announcement Date
Time
After Market Closes
Conference Call
4:30 PM ET

What Analysts Expect from Seer in Q3 2026

Seer is expected to post earnings of -$0.26 per share on revenue of $4.15 million. In the same quarter a year earlier Seer reported -$0.32 per share on revenue of $4.12 million. Seer last reported on August 11, 2026, posting -$0.31 per share and missing the -$0.27 consensus estimate. Seer has beaten the consensus EPS estimate in 5 of its last 8 quarters.

Consensus Estimates

Consensus EPS
-$0.26
Expected Revenue
$4.15 million
Prior-Year EPS
-$0.32
Prior-Year Revenue
$4.12 million
Expected Revenue Growth
+0.7%

Recent Track Record

Last Reported
Q2 2026
Last Quarter EPS
-$0.31 (Missed by -$0.04)
Last Quarter Revenue
$3.10 million
EPS Beat Rate
5 of last 8 quarters

Seer Q3 2026 Earnings FAQ

Seer (NASDAQ:SEER) is estimated to report Q3 2026 earnings on Tuesday, November 10, 2026, after market closes. This date is estimated from past reporting schedules and may change once the company confirms it.

Seer's Q3 2026 earnings conference call is scheduled for Tuesday, November 10, 2026 at 4:30 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect Seer to post earnings of -$0.26 per share for Q3 2026.

The consensus revenue estimate for Seer is $4.15 million for Q3 2026.

Seer Earnings Headlines

U.S. Army Advances 75-Year Rare Earth Deal With Nasdaq Firm
The Pentagon is moving to cut US dependence on Chinese rare earth metals, and a Nasdaq-listed company just signed a term sheet for a potential 75-year agreement with the US Army. The proposed deal would let the company build and operate a rare earth processing facility on an active military base, with the Army getting first right to production. New Pentagon restrictions on Chinese-origin rare earth magnets take effect January 1, 2027. The company's mine-to-magnet platform covers feedstock agreements, processing, metallization, and downstream manufacturing, with commercial output targeted for 2027.tc pixel
See More Seer Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Seer? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Seer and other key companies, straight to your email.

About Seer

Seer (NASDAQ:SEER) is a life sciences company that develops technologies for large-scale protein analysis, known as proteomics. The company’s platform is designed to help researchers study a broad range of proteins in biological samples and generate detailed information that may support drug discovery, disease research and biomarker development.

Seer’s primary offering is the Proteograph Product Suite, which combines engineered nanoparticle technology, laboratory consumables, automation and software. The system is intended to provide deep, unbiased proteomic analysis from relatively small biological samples, including blood and other complex specimens.

The company serves pharmaceutical and biotechnology companies, academic and research institutions, and other organizations involved in life sciences research. Seer is headquartered in Redwood City, California, and its products are marketed for research applications in domestic and international markets.

View Seer Profile